Analyst Ratings for Seres Therapeutics (MCRB)
MCRB Rating Summary
MCRB Price Target Summary
- Highest: $22.00 (Canaccord)
- Lowest: $22.00 (Canaccord)
- Average: $22.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$22.00 (+232.8%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/8/2025 | Chardan | Keay Nakae | Downgrade | Neutral (Buy) |
6.00 (N/A) |
8.29 (6.61) |
-20.27% | Details |
| 10/24/2024 | JPMorgan | Tessa Romero | Downgrade | Underweight (Neutral) |
N/A (N/A) |
0.78 (6.61) |
747.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
